Cocokara Fine Incorporated operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cocokara Fine Incorporated with three other
companies in this sector in Japan:
Create SD Holdings Co Limited
sales of 286.30 billion Japanese Yen [US$2.63 billion]
of which 39%
AIN Holdings Inc
(275.60 billion Japanese Yen [US$2.53 billion]
of which 89%
was Pharmacy Business), and
Sugi Holdings Company Limited
(488.46 billion Japanese Yen [US$4.48 billion]
of which 100%
was Drug Compounding Business).
During the year ended March of 2019, sales at
Cocokara Fine Incorporated were ¥400.56 billion (US$3.67 billion).
increase of 2.5%
versus 2018, when the company's sales were ¥390.96 billion.
This was the fourth straight year of sales growth at Cocokara Fine Incorporated.
Sales of Care saw an increase
that was more than double the company's growth rate: sales were up
27.5% in 2019, from
¥2.48 billion to ¥3.17 billion.